Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers

Ovarian cancer (OC), one of the most common malignancies of the female reproductive system, is characterized by high incidence and poor prognosis. Tumor mutation burden (TMB), as an important biomarker that can represent the degree of tumor mutation, is emerging as a key indicator for predicting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Mengjing, Xia, Qianqian, Zhang, Xing, Yan, Wenjing, Meng, Dan, Xie, Shuqian, Shen, Siyuan, Jin, Hua, Wang, Shizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787320/
https://www.ncbi.nlm.nih.gov/pubmed/35087563
http://dx.doi.org/10.3389/fgene.2021.688207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787320/
https://www.ncbi.nlm.nih.gov/pubmed/35087563
http://dx.doi.org/10.3389/fgene.2021.688207

Ejemplares similares